What is the 13F Pro Quality Score for ABPWW?

13F Pro ranks Abpro Holdings, Inc. (ABPWW) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View ABPWW's current score at https://13fpro.ai/company/ABPWW (free sign-up required for the full ranking).

Which hedge funds own the most ABPWW stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of ABPWW include VANGUARD GROUP, GOLDMAN SACHS GROUP, GEODE CAPITAL MANAGEMENT,. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/company/ABPWW as soon as new 13F filings post.

Where does 13F Pro source ABPWW data?

All Abpro Holdings, Inc. fundamentals and ownership data come directly from SEC EDGAR. Abpro Holdings, Inc. files with the SEC under CIK 1893219. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is ABPWW in?

Abpro Holdings, Inc. (ABPWW) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is ABPWW research updated on 13F Pro?

ABPWW's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Abpro Holdings, Inc.(ABPWW)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1893219 ABPWW stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 35 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

ABPWW Stock Analysis & AI Quality Score

Data updated 2026-07-26

AI stock analysis and institutional research for Abpro Holdings, Inc. (ABPWW), a Healthcare sector company. ABPWW is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 35 institutional filers currently hold this stock. Top institutional holders of ABPWW by reported 13-F value include VANGUARD GROUP, GOLDMAN SACHS GROUP, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. ABPWW trades on the Nasdaq exchange and files with the SEC under CIK 1893219. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ABPWW daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Abpro Holdings, Inc. directly from SEC EDGAR.

✦

Fun facts about Abpro Holdings, Inc.

Quirks, history, and lore behind ABPWW — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. biotechnology company · small-cap · listed on Nasdaq · headquartered in Massachusetts.
2
The Numbers
A pre-revenue, clinical-stage biotech — meaning it spends more than it earns and its future is riding entirely on pipeline success, not current sales.
3
The History
Founded in the 2010s, it was built around a proprietary platform for engineering antibody therapeutics, the cutting-edge backbone of modern cancer and autoimmune drug development.
4
The Secret
Its core technology focuses on generating fully human antibodies with enhanced precision — aiming to out-target conventional biologics by hitting targets others can't reach.
5
The Lore
The company trades under a ticker ending in WW, a telltale sign it went public via a SPAC warrant structure rather than a traditional IPO.
6
The Giveaway
A Woburn, MA antibody biotech that went public through a SPAC, develops bispecific and multispecific antibodies, and has a ticker that starts with the letters ABP.

▶ Think you know your stocks? Play the Daily Ticker

Net Income

Q2 2026

$-940.0K

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

—FY 2025

FY22 —FY23 $122.0KFY24 $183.0KFY25 —

Net Income

—FY 2025

FY22 $886.9KFY23 $2.8MFY24 —FY25 —

Operating Income

+14.8% YoY

$-8.5MFY 2025

FY22 $-2.1MFY23 $-1.7MFY24 $-9.9MFY25 $-8.5M

EPS (Diluted)

-74.8% YoY

$-1.30FY 2025

FY22 —FY23 $-0.02FY24 $-0.74FY25 $-1.30

Total Assets

-77.2% YoY

$1.1MFY 2025

FY22 $310.6MFY23 $37.4MFY24 $4.7MFY25 $1.1M

Op. Cash Flow

+33.5% YoY

$-6.0MFY 2025

FY22 $-1.2MFY23 $-3.8MFY24 $-9.0MFY25 $-6.0M

Free Cash Flow

—FY 2025

FY22 —FY23 $-3.9MFY24 —FY25 —

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Revenue	—	$183.0K +50.0%	$122.0K	—	—
Net Income	—	—	$2.8M +218.1%	$886.9K	—
Operating Income	$-8.5M +14.8%	$-9.9M -495.5%	$-1.7M +18.7%	$-2.1M	—
EPS (Diluted)	$-1.30 -74.8%	$-0.74 -3563.5%	$-0.02	—	—
Total Assets	$1.1M -77.2%	$4.7M -87.5%	$37.4M -88.0%	$310.6M +85839.3%	$361.4K
Operating Cash Flow	$-6.0M +33.5%	$-9.0M -134.8%	$-3.8M -224.5%	$-1.2M	—
Free Cash Flow	—	—	$-3.9M	—	—

Get alerted when ABPWW's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Abpro Holdings, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of ABPWW

VANGUARD GROUP INC
$85.0K20,084 sh
GOLDMAN SACHS GROUP INC
$52.4K12,383 sh
GEODE CAPITAL MANAGEMENT, LLC
$45.6K10,785 sh
Saba Capital Management, L.P.
$16.4K997,048 sh
JPMORGAN CHASE & CO
$12.2K873,533 sh
MMCAP International Inc. SPC
$11.1K675,000 sh
Calamos Advisors LLC
$10.6K625,000 sh
AQR Arbitrage LLC
$9.0K546,540 sh
LMR Partners LLP
$8.8K2,084 sh
LINDEN ADVISORS LP
$8.5K499,999 sh

Fund	Value	Shares
VANGUARD GROUP INC	$85.0K	20,084
GOLDMAN SACHS GROUP INC	$52.4K	12,383
GEODE CAPITAL MANAGEMENT, LLC	$45.6K	10,785
Saba Capital Management, L.P.	$16.4K	997,048
JPMORGAN CHASE & CO	$12.2K	873,533
MMCAP International Inc. SPC	$11.1K	675,000
Calamos Advisors LLC	$10.6K	625,000
AQR Arbitrage LLC	$9.0K	546,540
LMR Partners LLP	$8.8K	2,084
LINDEN ADVISORS LP	$8.5K	499,999

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABSI

Absci Corp

ABT

ABBOTT LABORATORIES

Put ABPWW on your watchlist

Track score changes the day Abpro Holdings, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is ABPWW a good stock to buy?

13F Pro's AI-powered analysis of Abpro Holdings, Inc. (ABPWW) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ABPWW are available on the ABPWW stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ABPWW is classified as a small company.

Which hedge funds own ABPWW?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ABPWW. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Abpro Holdings, Inc.'s investment landscape.